Spots Global Cancer Trial Database for methotrexate (mtx)
Every month we try and update this database with for methotrexate (mtx) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma | NCT05135858 | Primary Central... | Glucarpidase Methotrexate (M... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage | NCT00890656 | Acute Lymphobla... | Cyclophosphamid... Vincristine Doxorubicin Decadron G-CSF Methotrexate (M... Ara-C Pegaspargase | - | M.D. Anderson Cancer Center | |
Treatment of High Risk Adult Acute Lymphoblastic Leukemia | NCT00853008 | Acute Lymphobla... | Vincristine Daunorubicin Prednisone Mitoxantrone Cytosine Arabin... Dexamethasone Methotrexate (M... Cytarabine ASP Mercaptopurine Teniposide Hydrocortisone | 16 Years - | PETHEMA Foundation | |
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation | NCT06252870 | Graft Versus Ho... Hematologic Mal... | Methotrexate Post-Transplant... Fludarabine Cycophosphamide Anti-Thymoglobu... total body irra... hematopoietic s... Graft nuclear c... Donor Lymphocyt... Clofarabine Thiotepa Busulfan Fludarabine | 18 Years - 70 Years | Nantes University Hospital | |
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation | NCT06252870 | Graft Versus Ho... Hematologic Mal... | Methotrexate Post-Transplant... Fludarabine Cycophosphamide Anti-Thymoglobu... total body irra... hematopoietic s... Graft nuclear c... Donor Lymphocyt... Clofarabine Thiotepa Busulfan Fludarabine | 18 Years - 70 Years | Nantes University Hospital | |
A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSL | NCT05036577 | Primary Central... | Orelabrutinib Rituximab Methotrexate (M... Dexamethasone | 18 Years - 75 Years | Huashan Hospital | |
Treatment of High Risk Adult Acute Lymphoblastic Leukemia | NCT00853008 | Acute Lymphobla... | Vincristine Daunorubicin Prednisone Mitoxantrone Cytosine Arabin... Dexamethasone Methotrexate (M... Cytarabine ASP Mercaptopurine Teniposide Hydrocortisone | 16 Years - | PETHEMA Foundation | |
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation | NCT06252870 | Graft Versus Ho... Hematologic Mal... | Methotrexate Post-Transplant... Fludarabine Cycophosphamide Anti-Thymoglobu... total body irra... hematopoietic s... Graft nuclear c... Donor Lymphocyt... Clofarabine Thiotepa Busulfan Fludarabine | 18 Years - 70 Years | Nantes University Hospital | |
Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma | NCT05135858 | Primary Central... | Glucarpidase Methotrexate (M... | 18 Years - | Assistance Publique - Hôpitaux de Paris |